-
Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized TrialsFerrante G, Rao SV, Valgimigli M et al. -
Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic StentsS Sorrentino , G Giustino, GD Dangas et al
-
How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVDHong KN, Fuster V, Bhatt DL et al.
-
The HACD4 haplotype as a risk factor for atherosclerosis in malesZivotić I, Djurić T, Zivković M et al.
-
Long-Term Outcomes in Women and Men Following Percutaneous Coronary InterventionI Kosmidou, R Mehran, GW Stone et al.
-
A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trialde Winter RJ, Katagiri Y, Serruys PW et al.
-
Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance DocumentE Spitzer, E Mc Fadden, P Vranckx et al.
-
Long-term Survival following Multivessel Revascularization in Patients with Diabetes (FREEDOM Follow-On Study)Farkouh ME, Domanski M, FREEDOM Follow-On study investigators.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
